Geisinger Medical Laboratories Test Catalog

Order Display Name: Geisinger Epic Procedure Code Or ID CPT Code:  

FECAL OCCULT BLOOD, EIA

Geisinger Epic Procedure Code: LAB2269             Geisinger Epic ID: 29481
       

SPECIMEN COLLECTION
Specimen type:
Random stool
Preferred collection container:
Specimen required:
Inpatient / ED: Non-sterile specimen container
Off-site specimen: FOBT Collection Vial
Special notes:
Offsite specimens: Do not overfill collection vial. All fields (Collection Date, Name, MRN, or DOB if MRN is not available) in the label must be filled out. Patient Instructions
Inpatient / ED: Testing limited to pediatric patients only. Collect feces in a clean leak-proof container. Do not add fixative or preservative.
Patient preparation:
Patients with hemorrhoids or menstrual bleeding should wait until bleeding ceases.

SPECIMEN PROCESSING
Transport temperature:
Room temperature (preferred) or refrigerated.
Specimen stability:
Collection vial: Room temperature: 6 days. Refrigerated: 30 days.
Non-sterile containers: 24 hours.
Rejection criteria:
Overfilled specimens: samples that are not liquid enough to place drops on the cartridge. Specimen that does not have fecal matter added to the collection vial and the liquid in the vial is clear. Specimen past the stability limits.

TEST DETAILS
Reference interval:
Negative.
Interpretation guide:
Positive test indicates the presence of human hemoglobin (blood) in stool. May be upper GI or lower GI.
CPT code(s):
82274
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.  The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.
Test includes:
Immunoassay for human hemoglobin.
Methodology:
Immunoassay
Synonyms:
Hemosure iFOBT
Fecal Occult Blood Test
Occult blood test
FIT, iFOBT, FOBT
Immunological FOBT
Occult Blood Screen (EIA Mail in)
Clinical significance:
This test detects the presence of human hemoglobin in stool that may be of gastrointestinal or colorectal origin. It is used as a screen to detect polyps and lesions before they become cancerous.
Doctoral Director(s:)
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM
Sheng-Ying (Margaret) Lo, PhD, DABCC    
Review Date: 12/14/2022

Performing Locations

Geisinger Medical Center

Performing laboratory: Stat Lab
Technical Lead: Karen Delp
Frequency: Daily, all shifts
Performed STAT? Yes

Geisinger Wyoming Valley Medical Center

Performing laboratory: ATL+
Technical Lead: Mary Glazenski    
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger Shamokin Area Community Hospital

Performing laboratory: Serology
Technical Lead: Valerie Koveleski    
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger Bloomsburg Hospital

Performing laboratory: Chemistry
Technical Lead: Robyn Stokes  
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger Community Medical Center

Performing laboratory: Microbiology
Technical Lead: Ann Tomasello  
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger Lewistown Hospital

Performing laboratory: Microbiology
Technical Lead: Jane Kifer  
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger Medical Center Muncy

Performing laboratory: Stat Lab
Technical lead: Mariana Moyer    
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger Jersey Shore Hospital

Performing laboratory: Chemistry
Technical lead: Emily Haines    
Frequency: Daily, all shifts    
Performed STAT? Yes

Geisinger South Wilkes-Barre

Technical lead: Bernadette Johnson    
Frequency: Daily, all shifts    
Performed STAT? Yes
Locations  |    Search  |    Site Map |   Contact Us
©2000-2024 Geisinger Health System.   All rights reserved.